These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 11275363)
21. [Study on the effects of taxol on Hep-2 cell lines in larynx carcinoma]. Ni G; Dong Y; Wang J Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 13(6):265-7. PubMed ID: 12563982 [TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamics of taxol in human head and neck tumors. Gan Y; Wientjes MG; Schuller DE; Au JL Cancer Res; 1996 May; 56(9):2086-93. PubMed ID: 8616855 [TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer. Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of taxol on two human cancer cell lines. Banerjee S; Fallis AG; Brown DL Oncol Res; 1997; 9(5):237-48. PubMed ID: 9306431 [TBL] [Abstract][Full Text] [Related]
25. Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest. Ling X; Bernacki RJ; Brattain MG; Li F J Biol Chem; 2004 Apr; 279(15):15196-203. PubMed ID: 14722122 [TBL] [Abstract][Full Text] [Related]
26. Paclitaxel/Taxol sensitivity in human renal cell carcinoma is not determined by the p53 status. Reinecke P; Kalinski T; Mahotka C; Schmitz M; Déjosez M; Gabbert HE; Gerharz CD Cancer Lett; 2005 May; 222(2):165-71. PubMed ID: 15863265 [TBL] [Abstract][Full Text] [Related]
27. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. Gupta N; Hu LJ; Deen DF Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):885-95. PubMed ID: 9128966 [TBL] [Abstract][Full Text] [Related]
28. Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein. Ponnathpur V; Ibrado AM; Reed JC; Ray S; Huang Y; Self S; Bullock G; Nawabi A; Bhalla K Clin Cancer Res; 1995 Nov; 1(11):1399-406. PubMed ID: 9815937 [TBL] [Abstract][Full Text] [Related]
29. Phorbol myristate induces apoptosis of taxol-resistant sarcoma cells in vitro. Zong ZP; Matsui S; Katsuda S; Han JF; Fujikawa-Yamamoto K Eur J Pharmacol; 2004 Apr; 489(1-2):3-11. PubMed ID: 15063149 [TBL] [Abstract][Full Text] [Related]
30. [Inhibition of human laryngeal cancer Hep-2 cells by taxol]. Jiang X; Chen W; Cui P; Zhang D; Zhang Z Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jun; 17(6):342-5. PubMed ID: 14503369 [TBL] [Abstract][Full Text] [Related]
31. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity. Menendez JA; Vellon L; Colomer R; Lupu R Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900 [TBL] [Abstract][Full Text] [Related]
32. The mode of action of taxol: apoptosis at low concentration and necrosis at high concentration. Yeung TK; Germond C; Chen X; Wang Z Biochem Biophys Res Commun; 1999 Sep; 263(2):398-404. PubMed ID: 10491305 [TBL] [Abstract][Full Text] [Related]
33. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines. Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184 [TBL] [Abstract][Full Text] [Related]
34. Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells. Chiu CC; Li CH; Ung MW; Fuh TS; Chen WL; Fang K Cancer Lett; 2005 Jun; 223(2):249-58. PubMed ID: 15896459 [TBL] [Abstract][Full Text] [Related]
35. Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells. Tan G; Heqing L; Jiangbo C; Ming J; Yanhong M; Xianghe L; Hong S; Li G Int J Cancer; 2002 Jan; 97(2):168-72. PubMed ID: 11774260 [TBL] [Abstract][Full Text] [Related]
36. Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death. Sleiman RJ; Stewart BW Clin Cancer Res; 2000 Sep; 6(9):3756-65. PubMed ID: 10999770 [TBL] [Abstract][Full Text] [Related]
37. Taxol induces concentration-dependent apoptotic and paraptosis-like cell death in human lung adenocarcinoma (ASTC-a-1) cells. Guo WJ; Chen TS; Wang XP; Chen R J Xray Sci Technol; 2010; 18(3):293-308. PubMed ID: 20714087 [TBL] [Abstract][Full Text] [Related]
38. Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors. McDonald AC; Brown R Br J Cancer; 1998 Sep; 78(6):745-51. PubMed ID: 9743293 [TBL] [Abstract][Full Text] [Related]
39. The possible correlation between activation of NF-kappaB/IkappaB pathway and the susceptibility of tumor cells to paclitaxel-induced apoptosis. Huang Y; Fang Y; Dziadyk JM; Norris JS; Fan W Oncol Res; 2002; 13(2):113-22. PubMed ID: 12392159 [TBL] [Abstract][Full Text] [Related]
40. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells. Smith PJ; Souès S; Gottlieb T; Falk SJ; Watson JV; Osborne RJ; Bleehen NM Br J Cancer; 1994 Nov; 70(5):914-21. PubMed ID: 7947097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]